Integer Holdings Corp

From the end of 2025, total debt increased $34 million to $1.219 billion and Non-GAAP net total debt increased $33 million to $1.223 billion, resulting in a leverage ratio of 3.3 times adjusted EBITDA as of October 2, 2026.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

In addition to the performance measures identified above, we believe that net total debt and leverage ratio provide meaningful measures of liquidity and a useful basis for assessing our ability to fund our activities, including the financing of acquisitions and debt repayments.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Net total debt is calculated as total principal amount of debt outstanding less cash and cash equivalents.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

We calculate leverage ratio as net total debt divided by adjusted EBITDA for the trailing 4 quarters.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

(l) Loss on extinguishment of debt consists of accelerated write-offs of unamortized deferred debt issuance costs and discounts, which are included in interest expense.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

(m) Debt conversion inducement expense relates to the partial exchange of the 2028 Convertible Notes and is recorded within Other loss, net in the Condensed Consolidated Statements of Operations.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Organic sales change is reported sales growth adjusted to remove the impact of foreign currency, the contribution of acquisitions and the strategic exit of the Portable Medical market.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

For the strategic exit of the Portable Medical market, we exclude the impact on the growth rate attributable to Portable Medical sales for all periods presented.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Amounts for the third quarter and first nine months of 2026 include $2.2 million and $5.0 million, respectively, relating to our global manufacturing alignment restructuring initiative.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

In addition, the third quarter and first nine months of 2026 includes $0.6 million and $3.0 million, respectively, related to an organizational realignment to enhance execution of our strategy through dedicated focus on growth and operational excellence.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

Amounts for the third quarter and first nine months of 2026 include $0.7 million and $2.5 million, respectively, of expense incurred in connection with the Company s defense of a securities class action lawsuit.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

We have based these forward-looking statements on our current expectations, and these statements are subject to known and unknown risks, uncertainties and assumptions.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026

All such forward-looking statements are based upon current plans, estimates, expectations, opportunities and ambitions that are subject to risks, uncertainties, assumptions, and other important factors, many of which are beyond the control of the Company, that could cause actual results to differ materially from those expressed in such forward-looking statements.

SEC original ↗Integer Holdings Corp — Earnings release (8-K exhibit)EX-99Oct 29, 2026